Analysis of 3-Dimensional Arch Anatomy, Vascular Flow, and Postnatal Outcome in Cases of Suspected Coarctation of the Aorta Using Fetal Cardiac Magnetic Resonance Imaging.


Journal

Circulation. Cardiovascular imaging
ISSN: 1942-0080
Titre abrégé: Circ Cardiovasc Imaging
Pays: United States
ID NLM: 101479935

Informations de publication

Date de publication:
07 2021
Historique:
pubmed: 1 7 2021
medline: 30 11 2021
entrez: 30 6 2021
Statut: ppublish

Résumé

Identifying fetuses at risk of severe neonatal coarctation of the aorta (CoA) can be lifesaving but is notoriously challenging in clinical practice with a high rate of false positives. Novel fetal 3-dimensional and phase-contrast magnetic resonance imaging (MRI) offers an unprecedented means of assessing the human fetal cardiovascular system before birth. We performed detailed MRI assessment of fetal vascular morphology and flows in a cohort of fetuses with suspected CoA, correlated with the need for postnatal intervention. Women carrying a fetus with suspected CoA on echocardiography were referred for MRI assessment between 26 and 36 weeks of gestation, including high-resolution motion-corrected 3-dimensional volumes of the fetal heart and phase-contrast flow sequences gated with metric optimized gating. The relationship between aortic geometry and vascular flows was then analyzed and compared with postnatal outcome. Seventy-two patients (51 with suspected fetal CoA and 21 healthy controls) underwent fetal MRI with motion-corrected 3-dimensional vascular reconstructions. Vascular flow measurements from phase-contrast sequences were available in 53 patients. In the CoA group, 25 of 51 (49%) required surgical repair of coarctation after birth; the remaining 26 of 51 (51%) were discharged without neonatal intervention. Reduced blood flow in the fetal ascending aorta and at the aortic isthmus was associated with increasing angulation ( Reduced blood flow though the left heart is associated with important configurational changes at the aortic isthmus in fetal life, predisposing to CoA when the arterial duct closes after birth. Novel fetal MRI techniques may have a role in both understanding and accurately predicting severe neonatal CoA.

Sections du résumé

BACKGROUND
Identifying fetuses at risk of severe neonatal coarctation of the aorta (CoA) can be lifesaving but is notoriously challenging in clinical practice with a high rate of false positives. Novel fetal 3-dimensional and phase-contrast magnetic resonance imaging (MRI) offers an unprecedented means of assessing the human fetal cardiovascular system before birth. We performed detailed MRI assessment of fetal vascular morphology and flows in a cohort of fetuses with suspected CoA, correlated with the need for postnatal intervention.
METHODS
Women carrying a fetus with suspected CoA on echocardiography were referred for MRI assessment between 26 and 36 weeks of gestation, including high-resolution motion-corrected 3-dimensional volumes of the fetal heart and phase-contrast flow sequences gated with metric optimized gating. The relationship between aortic geometry and vascular flows was then analyzed and compared with postnatal outcome.
RESULTS
Seventy-two patients (51 with suspected fetal CoA and 21 healthy controls) underwent fetal MRI with motion-corrected 3-dimensional vascular reconstructions. Vascular flow measurements from phase-contrast sequences were available in 53 patients. In the CoA group, 25 of 51 (49%) required surgical repair of coarctation after birth; the remaining 26 of 51 (51%) were discharged without neonatal intervention. Reduced blood flow in the fetal ascending aorta and at the aortic isthmus was associated with increasing angulation (
CONCLUSIONS
Reduced blood flow though the left heart is associated with important configurational changes at the aortic isthmus in fetal life, predisposing to CoA when the arterial duct closes after birth. Novel fetal MRI techniques may have a role in both understanding and accurately predicting severe neonatal CoA.

Identifiants

pubmed: 34187165
doi: 10.1161/CIRCIMAGING.121.012411
pmc: PMC8300852
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e012411

Subventions

Organisme : British Heart Foundation
ID : TA/F/20/210021
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 102431
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Références

Ultrasound Obstet Gynecol. 2002 Oct;20(4):332-9
pubmed: 12383313
Prenat Diagn. 2016 Feb;36(2):127-34
pubmed: 26630206
Prenat Diagn. 2020 Jul;40(8):942-948
pubmed: 32277716
Ultrasound Obstet Gynecol. 2015 Jun;45(6):664-9
pubmed: 25296951
Sci Rep. 2020 Jan 21;10(1):880
pubmed: 31964989
Nat Commun. 2020 Dec 14;11(1):6413
pubmed: 33318490
Pediatr Cardiol. 1998 Mar-Apr;19(2):182-4
pubmed: 9565515
Heart. 2005 Nov;91(11):1495-502
pubmed: 16230458
Pediatr Cardiol. 2020 Apr;41(4):772-780
pubmed: 32034462
Circulation. 2017 Feb 21;135(8):772-785
pubmed: 28034902
Ultrasound Obstet Gynecol. 2020 Dec;56(6):850-856
pubmed: 31875324
Br Heart J. 1979 Mar;41(3):268-74
pubmed: 426975
Lancet. 2019 Apr 20;393(10181):1619-1627
pubmed: 30910324
Heart Vessels. 2014 May;29(3):354-63
pubmed: 23748371
IEEE Trans Med Imaging. 2020 Sep;39(9):2750-2759
pubmed: 32086200
Fetal Diagn Ther. 2016;40(2):81-93
pubmed: 27379710
Ann Thorac Surg. 2005 Nov;80(5):1652-7
pubmed: 16242433
Edinb Med Surg J. 1841 Oct 1;56(149):427-462
pubmed: 30331130
Heart. 2005 Aug;91(8):1070-4
pubmed: 16020599
Am J Pathol. 1971 May;63(2):203-14
pubmed: 5090637
Magn Reson Med. 2019 Sep;82(3):1055-1072
pubmed: 31081250
Ultrasound Obstet Gynecol. 2017 May;49(5):623-629
pubmed: 27072120
Acta Paediatr. 2006 Apr;95(4):407-13
pubmed: 16720486
Ultrasound Obstet Gynecol. 2003 Nov;22(5):441-7
pubmed: 14618654
Pediatrics. 1975 Oct;56(4):562-9
pubmed: 1165960
Magn Reson Med. 2010 Nov;64(5):1304-14
pubmed: 20632406
Pediatr Cardiol. 2018 Jan;39(1):1-10
pubmed: 29043396
Heart. 2002 Jan;87(1):67-9
pubmed: 11751670
Ultrasound Obstet Gynecol. 2018 Nov;52(5):593-598
pubmed: 28598570
Heart. 2002 May;87(5):405-6
pubmed: 11997402
Circ Cardiovasc Imaging. 2013 Jul;6(4):499-507
pubmed: 23771987
Heart. 2017 Aug;103(15):1148-1155
pubmed: 28377475
Sci Rep. 2016 Dec 16;6:39304
pubmed: 27982102
PLoS One. 2013 Aug 27;8(8):e72394
pubmed: 24015239
Circulation. 2008 Oct 28;118(18):1793-801
pubmed: 18852365
Facts Views Vis Obgyn. 2012;4(4):230-6
pubmed: 24753914
Cardiol Young. 2015 Aug;25(6):1214-7
pubmed: 25275342
Radiology. 2013 Jun;267(3):902-10
pubmed: 23329652
Ultrasound Obstet Gynecol. 2012 Jul;40(1):47-54
pubmed: 22461316
Am J Cardiol. 1972 Oct;30(5):514-25
pubmed: 4672503
J Am Soc Echocardiogr. 2013 Dec;26(12):1379-87
pubmed: 24070640
Am J Perinatol. 1998 Apr;15(4):237-42
pubmed: 9565221
Circulation. 2005 Jun 21;111(24):3269-73
pubmed: 15956120

Auteurs

David F A Lloyd (DFA)

School of Imaging Sciences and Biomedical Engineering, King's College London, United Kingdom (D.F.A.L., M.P.M.v.P., K.P., J.S., J.F.P.v.A., T.R., A.S., M.R., J.H., R.R.).
Department of Congenital Heart Disease, Evelina London Children's Hospital, United Kingdom (D.F.A.L., K.P., T.V.V., V.Z., M.C., O.M., G.S., J.M.S., R.R.).

Milou P M van Poppel (MPM)

School of Imaging Sciences and Biomedical Engineering, King's College London, United Kingdom (D.F.A.L., M.P.M.v.P., K.P., J.S., J.F.P.v.A., T.R., A.S., M.R., J.H., R.R.).

Kuberan Pushparajah (K)

School of Imaging Sciences and Biomedical Engineering, King's College London, United Kingdom (D.F.A.L., M.P.M.v.P., K.P., J.S., J.F.P.v.A., T.R., A.S., M.R., J.H., R.R.).
Department of Congenital Heart Disease, Evelina London Children's Hospital, United Kingdom (D.F.A.L., K.P., T.V.V., V.Z., M.C., O.M., G.S., J.M.S., R.R.).

Trisha V Vigneswaran (TV)

Department of Congenital Heart Disease, Evelina London Children's Hospital, United Kingdom (D.F.A.L., K.P., T.V.V., V.Z., M.C., O.M., G.S., J.M.S., R.R.).

Vita Zidere (V)

Department of Congenital Heart Disease, Evelina London Children's Hospital, United Kingdom (D.F.A.L., K.P., T.V.V., V.Z., M.C., O.M., G.S., J.M.S., R.R.).

Johannes Steinweg (J)

School of Imaging Sciences and Biomedical Engineering, King's College London, United Kingdom (D.F.A.L., M.P.M.v.P., K.P., J.S., J.F.P.v.A., T.R., A.S., M.R., J.H., R.R.).

Joshua F P van Amerom (JFP)

School of Imaging Sciences and Biomedical Engineering, King's College London, United Kingdom (D.F.A.L., M.P.M.v.P., K.P., J.S., J.F.P.v.A., T.R., A.S., M.R., J.H., R.R.).

Thomas A Roberts (TA)

School of Imaging Sciences and Biomedical Engineering, King's College London, United Kingdom (D.F.A.L., M.P.M.v.P., K.P., J.S., J.F.P.v.A., T.R., A.S., M.R., J.H., R.R.).

Alexander Schulz (A)

School of Imaging Sciences and Biomedical Engineering, King's College London, United Kingdom (D.F.A.L., M.P.M.v.P., K.P., J.S., J.F.P.v.A., T.R., A.S., M.R., J.H., R.R.).

Marietta Charakida (M)

Department of Congenital Heart Disease, Evelina London Children's Hospital, United Kingdom (D.F.A.L., K.P., T.V.V., V.Z., M.C., O.M., G.S., J.M.S., R.R.).

Owen Miller (O)

Department of Congenital Heart Disease, Evelina London Children's Hospital, United Kingdom (D.F.A.L., K.P., T.V.V., V.Z., M.C., O.M., G.S., J.M.S., R.R.).

Gurleen Sharland (G)

Department of Congenital Heart Disease, Evelina London Children's Hospital, United Kingdom (D.F.A.L., K.P., T.V.V., V.Z., M.C., O.M., G.S., J.M.S., R.R.).

Mary Rutherford (M)

School of Imaging Sciences and Biomedical Engineering, King's College London, United Kingdom (D.F.A.L., M.P.M.v.P., K.P., J.S., J.F.P.v.A., T.R., A.S., M.R., J.H., R.R.).

Joseph V Hajnal (JV)

School of Imaging Sciences and Biomedical Engineering, King's College London, United Kingdom (D.F.A.L., M.P.M.v.P., K.P., J.S., J.F.P.v.A., T.R., A.S., M.R., J.H., R.R.).

John M Simpson (JM)

Department of Congenital Heart Disease, Evelina London Children's Hospital, United Kingdom (D.F.A.L., K.P., T.V.V., V.Z., M.C., O.M., G.S., J.M.S., R.R.).

Reza Razavi (R)

School of Imaging Sciences and Biomedical Engineering, King's College London, United Kingdom (D.F.A.L., M.P.M.v.P., K.P., J.S., J.F.P.v.A., T.R., A.S., M.R., J.H., R.R.).
Department of Congenital Heart Disease, Evelina London Children's Hospital, United Kingdom (D.F.A.L., K.P., T.V.V., V.Z., M.C., O.M., G.S., J.M.S., R.R.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH